Overproduction of the #DNARepair protein #exonuclease1 (#EXO1) in certain #cancers causes #DNADamage that mimics #BRCAmutations, potentially making these cancers responsive to the same #TargetedTreatments.
EXO1: DNA repair protein gene gone rogue may unlock new cancer treatments – BioNews Central
Overproduction of the DNA repair protein EXO1 in certain cancers causes DNA damage that mimics BRCA mutations, potentially making these cancers responsive to the same targeted treatments. ...
sbee.link
May 22, 2026 at 6:49 PM
Overproduction of the #DNARepair protein #exonuclease1 (#EXO1) in certain #cancers causes #DNADamage that mimics #BRCAmutations, potentially making these cancers responsive to the same #TargetedTreatments.
#prostatecancerscreening #prostatecancer #menshealth #UKNationalScreeningCommittee #UKNSC #targetedprostatecancerscreening #ProstateCancerUK #ProstateCancerResearch #ChrisHoy #CancerResearchUK #RoyalCollegeofGPs #BRCAmutations #ERSPCstudy #TRANSFORMclinicaltrial #IMPACTscreeningtrial
zurl.co/1dY3N
zurl.co/1dY3N
Limited prostate cancer screening backed in UK
A recommendation on prostate cancer screening has been delivered in the UK, upsetting patient groups whilst being endorsed by medical organisations.
pharmaphorum.com
December 3, 2025 at 10:50 AM
#precisionmedicine #PARPinhibitor #breastcancer #NICErecommended #olaparib #Lynparza #AstraZeneca #AstraZenecaUK #AstraZenecaOncology #genetictesting #OlympiADclinicaltrail #OlympiADphase3trial #BRCAmutations #TestingforBRCAmutations #NationalGenomicTestDirectory
pharmatimes.com/news/nice-re...
pharmatimes.com/news/nice-re...
NICE recommends olaparib for BRCA-mutated breast cancer treatment - PharmaTimes
Groundbreaking approval provides new hope for patients in England and Wales
pharmatimes.com
January 10, 2025 at 2:25 PM